Bund Yields Fall; Supply, ZEW Data Could Provide Support
0725 GMT – U.S. Treasury yields edge lower after rising last week following weak demand at auctions of three-year, 10-year and 30-year auctions. This caused the 10-year yield to hit its highest in a week. Trade calms on Monday as tariffs which took effect last week have so far had limited impact on markets. However, yields risk rising, Capital Economics' James Reilly says in a note. Weak Treasury auctions remind investors 'that huge public debt to GDP ratios are not going anywhere fast.' Tuesday's U.S. inflation data could also cause yields to rise if prices increase more than expected, he says. The 10-year Treasury yield falls 2 basis points to 4.264%, having hit a high of 4.289% on Friday, Tradeweb data show. (jessica.fleetham@wsj.com)
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
an hour ago
- Yahoo
Bitcoin Treasury KindlyMD Stock Dives Following $679 Million BTC Buy
Bitcoin treasury KindlyMD has added $679 million in BTC to its holdings, the company said Tuesday—though the firm's stock has taken a plunge following the announcement. The Nasdaq-listed company said that it had bought 5,743.91 BTC via its wholly owned subsidiary, Nakamoto Holdings, Inc, for an average price of about $118,205 per coin. Bitcoin was recently trading for $113,200, down 2.4% over a 24-hour period and by more than 5% over the past week after hitting a new all-time high mark above $124,000 last week. "This acquisition reinforces our conviction in Bitcoin as the ultimate reserve asset for corporations and institutions alike," David Bailey, the company's CEO said. Bitcoin Treasury KindlyMD Closes $200 Million Raise to Buy More BTC KindlyMD's stock—which trades under the ticker NAKA—was down by more than 13% Tuesday to a price of $10.41. The firm, which focuses on providing healthcare data, in May announced a merger with holding company Nakamoto. Nakamoto is a holding company co-founded by Bitcoin Magazine CEO David Bailey with the intent of purchasing Bitcoin. Bailey advised President Donald Trump on crypto policy while the Republican candidate was campaigning last year. KindlyMD said on Monday that it had closed a $200 million convertible note offering as part of its Bitcoin-buying strategy. It raised another $540 million in August via a private placement in public equity (PIPE) to buy the cryptocurrency. The move is straight out of Strategy's playbook: Raise cash to buy Bitcoin so investors can buy shares of a publicly traded company and get regulated exposure to the asset. Strategy shifted from software development to focus on Bitcoin accumulation in 2020. It is the largest corporate holder of the asset with 629,376 BTC worth over $71 billion. Some 168 public companies now have Bitcoin treasuries, according to holding a total of more than 983,000 Bitcoin. Some experts have warned that the crypto play has its risks, and that pivoting to crypto won't necessarily save a failing business. But companies keep popping up, and some are amassing billions of dollars' worth of digital assets. Other notable treasuries include Twenty One, started by a combination of crypto and traditional finance powerhouses—Tether, Bitfinex, Cantor Fitzgerald, and SoftBank. It holds 43,500 BTC—almost $5 billion worth as of this writing—although it has yet to begin trading. Sign in to access your portfolio
Bloomberg
2 hours ago
- Bloomberg
Cameroon to Issue Eurobond as Part of $1.7 Billion Borrowing
Cameroon is planning to issue a fresh eurobond as it prepares to raise 930 billion CFA francs ($1.7 billion) on the regional and the international capital markets. The proceeds will be used for development projects and the payment of debt arrears, President Paul Biya said in a decree on Tuesday. As much as 330 billion CFA francs will be raised from external sources, including a eurobond sale, Sylvester Moh Tangongho, director-general of the Treasury, said in emailed response to questions.
Yahoo
2 hours ago
- Yahoo
Stada Owners Are Said to Resume IPO Work as CapVest Talks Stall
(Bloomberg) -- Stada Arzneimittel AG's private equity owners are resuming preparations for a listing of the German drugmaker after talks stalled on a potential sale to CapVest Partners, people with knowledge of the matter said. Bain Capital and Cinven, which jointly own Stada, have started gearing up to hold an initial public offering of the business as soon as October, the people said. London-based buyout firm CapVest was in discussions to acquire Stada but it's been unable to reach an agreement, according to the people, who asked not to be identified because the information is private. Chicago Schools Seeks $1 Billion of Short-Term Debt as Cash Gone A Photographer's Pipe Dream: Capturing New York's Vast Water System Why New York City Has a Fleet of New EVs From a Dead Carmaker A London Apartment Tower With Echoes of Victorian Rail and Ancient Rome Princeton Plans New Budget Cuts as Pressure From Trump Builds CapVest was in talks to buy Stada together with a group of other institutional investors in a transaction valuing the business at around €10 billion ($11.7 billion) including debt, Bloomberg News has reported. The potential acquisition would have been a large deal for CapVest, which manages about €12 billion in assets. Talks cooled in part due to disagreements over valuation as well as the structure of CapVest's bid, according to some of the people. Bain and Cinven are now returning to plans for an IPO, which has always been their preferred exit route, the people said. While negotiations on a potential deal with CapVest have hit an impasse, the situation is fluid and there's still a chance they could overcome their differences and reach an agreement, the people said. Representatives for Bain, CapVest, Cinven and Stada declined to comment. Bain and Cinven started weighing options for Stada in 2023. The company manufactures and sells a range of products such as consumer health-care items, generic drugs and specialty medication for rare and chronic diseases. Stada told investors in June that it's on track to achieve its earnings guidance of €930 million to €990 million of adjusted Ebitda for the year. It's targeting €4.25 billion to €4.4 billion of adjusted revenues. The company's brands include Grippostad, which helps treat colds and flu infections, and Hirudoid cream for bruises and hematoma. Bain and Cinven agreed to buy Stada for €5.3 billion in 2017, a deal that gave them control of one of Europe's last independent generic-drug companies. --With assistance from Pamela Barbaglia. Foreigners Are Buying US Homes Again While Americans Get Sidelined What Declining Cardboard Box Sales Tell Us About the US Economy Women's Earnings Never Really Recover After They Have Children Americans Are Getting Priced Out of Homeownership at Record Rates Yosemite Employee Fired After Flying Trans Pride Flag ©2025 Bloomberg L.P. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
